US Patent 11446322 Methods of treating tumor metastasis
Patent 11446322 was granted and assigned to TARIS Biomedical on September, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Jul, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114463220
Date of Patent
September 20, 2022
0Patent Application Number
170787890
Date Filed
October 23, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 7 Apr, 2023
Golden AI
Infobox
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114463220
Date of Patent
September 20, 2022
0Patent Application Number
170787890
Date Filed
October 23, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 23 Mar, 2023
Golden AI
Edits on 24 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 21 Sep, 2022
Golden AI
Edits made to:
Infobox (+16 properties)
Article (+434 characters)
US Patent 11446322 Methods of treating tumor metastasis
Article
The present invention provides methods for treating or suppressing tumor metastasis at a site distinct from the bladder in an individual having a urothelial carcinoma of lower tract, comprising locally delivering to the bladder an effective amount of a chemotherapeutic agent (such as gemcitabine), wherein the chemotherapeutic agent is delivered continuously to the bladder for a sustained period of time (such as at least 24 hours).
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114463220
Date of Patent
September 20, 2022
0Patent Application Number
170787890
Date Filed
October 23, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11446322 Methods of treating tumor metastasis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
